Breaking News

How the biotech industry is being reshaped by the stock market; Biogen sells stake in Samsung venture

 

Pharmalot Ed Silverman

STAT+: 'Nowhere to hide': As biotech stocks plummet, an industry is being reshaped by the fallout

By Adam Feuerstein and Damian Garde and Matthew Herper

Mike Reddy for STAT

The decline in biotech has erased billions in value and led even seasoned investors to question whether the industry has further to fall.

Read More

STAT+: Biogen sells stake in Samsung venture for $2.3 billion

By Damian Garde and Adam Feuerstein

Steven Senn/AP

Samsung Biologics is acquiring Biogen’s ownership in Samsung Bioepis, which manufactures off-patent versions of biologic medicines called biosimilars.

Read More

STAT+: Up and down the ladder: the latest comings and goings

By Ed Silverman

Alex Hogan/STAT

From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry.

Read More

Early data indicate vaccines still protect against Omicron's sister variant, BA.2

By Andrew Joseph

SAJJAD HUSSAIN/AFP via Getty Images

New data show that vaccines still protect against a spinoff of the Omicron variant, a welcome sign about the latest coronavirus iteration.

Read More

Friday, January 28, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments